My Perspective as a Physician I think patients deserve honesty here
The evidence base is preclinical
Everyones needs differ, so the best plan fits your unique story
Because the compound is a metal complex, the methods section needs to state which species was used, how the copper content was established, what the medium contained by way of copper, chelators and reductants, and whether a copper-salt control was run
Cagrilintide (Cagri), functioning as a dual amylin receptor (AMYRs) and calcitonin receptor (CTR) agonist (DACRA), demonstrates significant efficacy in obesity treatment, although its structural activation mechanism remains unclear
Telling every patient "it will resolve" sets false expectations for the subset who need active management indefinitely